The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 09, 2024

Filed:

Apr. 06, 2021
Applicant:

Living Clean Nz, Ltd., Greenbrae, CA (US);

Inventors:

Gregory van Buskirk, Danville, CA (US);

Anne Steinemann, Townsville, AU;

Assignee:

Sensitive Home, Inc., Greenbrae, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C11D 1/83 (2006.01); C11D 1/66 (2006.01); C11D 1/74 (2006.01); C11D 3/00 (2006.01); C11D 3/20 (2006.01); C11D 3/43 (2006.01); C11D 11/00 (2006.01); C11D 17/00 (2006.01);
U.S. Cl.
CPC ...
C11D 1/662 (2013.01); C11D 1/667 (2013.01); C11D 1/74 (2013.01); C11D 3/0047 (2013.01); C11D 3/2006 (2013.01); C11D 3/2041 (2013.01); C11D 3/43 (2013.01); C11D 11/0017 (2013.01); C11D 11/0023 (2013.01); C11D 17/0008 (2013.01);
Abstract

The present disclosure relates to cleaning compositions in general, and cleaning compositions that are well suited for use by individuals, who experience adverse health effects that may occur upon exposure to certain chemicals. This condition, characterized as multiple chemical sensitivities (MCS), makes it virtually impossible for certain individuals to use commercially available cleaning products without inducing immunological responses. The disclosure presents and describes protocols for the formulation and evaluation of a variety of cleaning products and dilutable cleaning product concentrates using a combination ofC assay, head space analysis and screening of both ingredients and final products for governmentally-regulated materials. The methods and compositions newly presented herein avoid causing adverse health responses in individuals and are suitable for use by any person, particularly individuals who experience MCS.


Find Patent Forward Citations

Loading…